Status:

UNKNOWN

The Efficacy and Safety of Intradermal Acupuncture for Acute Herpes Zoster

Lead Sponsor:

The Third Affiliated hospital of Zhejiang Chinese Medical University

Conditions:

Herpes Zoster

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Herpes zoster (HZ), also commonly known as shingles, is characterized by a bandlike rash in the dermatome that corresponds to the affected nerve. Pain is prevalent in HZ patients, which may be provoke...

Detailed Description

This randomized controlled trial will enroll 72 eligible patients with acute herpes zoster. Participants who are confirmed eligibility will be randomly allocated to either the IDA group or the sham ID...

Eligibility Criteria

Inclusion

  • Participants have confirmed diagnosis of herpes zoster;
  • Herpes zoster is in the acute stage and participants have not yet received antiviral treatment or analgesic treatment;
  • 18≤Age≤80 years, regardless of gender;
  • Significant pain with a visual analog scale (VAS) score ≥ 4;
  • Absence of other diseases causing skin temperature change;
  • Participants can understand the study procedure and agree to sign the informed consent form.

Exclusion

  • Participants have some specific types of herpes zoster, such as disseminated herpes zoster; or herpes zoster is located on regions that are not suitable for intradermal acupuncture, such as the head, face, or perineum.
  • Pregnant or lactating subjects;
  • Participants have scar constitution or have severe cardiovascular, hepatic, renal, and hematopoietic system diseases that result in bleeding tendency, thereby making them unsuitable for intradermal acupuncture;
  • Participants with severe cognitive impairment who are unable to fully understand the trial protocol;
  • Participants are taking part in other trials.

Key Trial Info

Start Date :

July 4 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2024

Estimated Enrollment :

72 Patients enrolled

Trial Details

Trial ID

NCT05348382

Start Date

July 4 2022

End Date

December 1 2024

Last Update

July 18 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

the Third Affiliated Hospital of Zhejiang Chinese Medical University

Hangzhou, Zhejiang, China, 310000

2

The Third Affiliated Hospital of Zhejiang Chinese Medical University

Hangzhou, Zhejiang, China, 310000